- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5470
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma ; volume:23 ; number:3-4 ; day:7 ; month:5 ; year:2022 ; pages:129-140 ; date:6.2022
Genes and immunity ; 23, Heft 3-4 (7.5.2022), 129-140, 6.2022
- Urheber
-
Tang, Xao X.
Shimada, Hiroyuki
Ikegaki, Naohiko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41435-022-00172-w
- URN
-
urn:nbn:de:101:1-2022081723194441447755
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tang, Xao X.
- Shimada, Hiroyuki
- Ikegaki, Naohiko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cryo-thermal therapy induces macrophage polarization for durable anti-tumor immunity
Artificial Macrophage with Hierarchical Nanostructure for Biomimetic Reconstruction of Antitumor Immunity
Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis
TH9 cells in anti-tumor immunity
Anlotinib Combined with Anti‐PD1 Potentiates Anti‐Tumor Immunity via Immunogenic Cell Death and Macrophage Reprogramming
Induction of antitumor immunity through xenoplacental immunization
Cytokine-induced killer cells promote antitumor immunity
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma
Necroptosis stimulates interferon-mediated protective anti-tumor immunity
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Integrin CD11b activation drives anti-tumor innate immunity
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
Cryo-thermal therapy induces macrophage polarization for durable anti-tumor immunity
Artificial Macrophage with Hierarchical Nanostructure for Biomimetic Reconstruction of Antitumor Immunity
Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis
TH9 cells in anti-tumor immunity
Anlotinib Combined with Anti‐PD1 Potentiates Anti‐Tumor Immunity via Immunogenic Cell Death and Macrophage Reprogramming
Induction of antitumor immunity through xenoplacental immunization
Cytokine-induced killer cells promote antitumor immunity
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma
Necroptosis stimulates interferon-mediated protective anti-tumor immunity
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Integrin CD11b activation drives anti-tumor innate immunity
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
Cryo-thermal therapy induces macrophage polarization for durable anti-tumor immunity
Artificial Macrophage with Hierarchical Nanostructure for Biomimetic Reconstruction of Antitumor Immunity
Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis
TH9 cells in anti-tumor immunity
Anlotinib Combined with Anti‐PD1 Potentiates Anti‐Tumor Immunity via Immunogenic Cell Death and Macrophage Reprogramming
Induction of antitumor immunity through xenoplacental immunization
Cytokine-induced killer cells promote antitumor immunity
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma
Necroptosis stimulates interferon-mediated protective anti-tumor immunity
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Integrin CD11b activation drives anti-tumor innate immunity